A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Alefacept (Primary) ; Alefacept (Primary) ; Basiliximab; Mycophenolate mofetil; Steroids; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 07 Sep 2011 Results presented at the 15th Congress of the European Society for Organ Transplantation.
- 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
- 25 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History